Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 2/20 | 0.69 |
| ▸ | MAPT | P10636 | 4/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | GAA | P10253 | 3/20 | 0.64 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 3/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | BACE1 | P56817 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 1/20 | 0.52 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.52 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.52 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid Phenyl Ester SCHEMBL6422166 | 0.97 | ELANE (0.72) | ELANEMAPTALDH1A1GAAHSP90AA1 | |
| Acetic Acid Phenyl Ester SCHEMBL35500 | 0.97 | ELANE (0.72) | ELANEMAPTALDH1A1GAAHSP90AA1 | |
| Acetic Acid Phenyl Ester SCHEMBL181469 | 0.95 | ELANE (0.69) | ELANEMAPTALDH1A1GAAHSP90AA1 | |
| Acetic Acid Phenyl Ester SCHEMBL1404134 | 0.95 | ELANE (0.69) | ELANEMAPTALDH1A1GAAHSP90AA1 | |
| Acetic Acid Phenyl Ester SCHEMBL4343067 | 0.95 | ELANE (0.69) | ELANEMAPTALDH1A1GAAHSP90AA1 | |
| Acetic Acid Phenyl Ester SCHEMBL11787346 | 0.95 | ELANE (0.69) | ELANEMAPTALDH1A1GAAHSP90AA1 | |
| Acetic Acid Phenyl Ester SCHEMBL11483885 | 0.95 | ELANE (0.69) | ELANEMAPTALDH1A1GAAHSP90AA1 | |
| Acetic Acid Phenyl Ester SCHEMBL388843 | 0.95 | ELANE (0.69) | ELANEMAPTALDH1A1GAAHSP90AA1 | |
| Acetic Acid Phenyl Ester SCHEMBL1309661 | 0.95 | ELANE (0.69) | ELANEMAPTALDH1A1GAAHSP90AA1 | |
| Acetic Acid Phenyl Ester SCHEMBL9154639 | 0.95 | ELANE (0.69) | ELANEMAPTALDH1A1GAAHSP90AA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110494805-A | Silver composition and purposes containing cellulosic polymer | EASTMAN KODAK CO | 2019-11-22 | — | — | CN | claimed |
| EP-2625162-B1 | METHODS OF MAKING L-ORNITHINE PHENYL ACETATE | OCERA THERAPEUTICS INC (US) | 2019-03-13 | — | — | EP | claimed |
| US-8946473-B2 | Methods of making L-ornithine phenyl acetate | OCERA THERAPEUTICS, INC. (US) | 2015-02-03 | — | — | US | claimed |
| US-20130211135-A1 | METHODS OF MAKING L-ORNITHINE PHENYL ACETATE | OCERA THERAPEUTICS, INC. (US) | 2013-08-15 | — | — | US | claimed |
| EP-2625162-A1 | METHODS OF MAKING L-ORNITHINE PHENYL ACETATE | Ocera Therapeutics Inc. (US) | 2013-08-14 | — | — | EP | claimed |
| WO-2012048043-A1 | METHODS OF MAKING L-ORNITHINE PHENYL ACETATE | OCERA THERAPEUTICS, INC. (US) | 2012-04-12 | — | — | WO | claimed |
| EP-2413924-A1 | L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF | Ocera Therapeutics, INC. (US) | 2012-02-08 | — | — | EP | claimed |
| US-20100280119-A1 | L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF | OCERA THERAPEUTICS, INC. (US) | 2010-11-04 | — | — | US | claimed |
| WO-2010115055-A1 | L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF | OCERA THERAPEUTICS, INC. (US) | 2010-10-07 | — | — | WO | claimed |
| US-4036650-A | SILVER SALT, SILVER HALIDE, REDUCING AGENT | CANON KABUSHIKI KAISHA (JA) | 1977-07-19 | — | — | US | claimed |
| US-12516015-B2 | L-ornithine phenyl acetate and methods of making thereof | AMALIVE LIMITED (GB) | 2026-01-06 | — | — | US | disclosed |
| WO-2024261477-A1 | COMBINATION OF TLR4 ANTAGONIST, ORNITHINE AND PHENYLACETATE OR PHENYLBUTYRATE | YAQRIT LIMITED (GB) | 2024-12-26 | — | — | WO | disclosed |
| EP-4101838-A1 | L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF | Ocera Therapeutics, Inc. (US) | 2022-12-14 | — | — | EP | disclosed |
| EP-3686183-B1 | L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF | OCERA THERAPEUTICS INC (US) | 2022-08-03 | — | — | EP | disclosed |
| US-20220162155-A1 | L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF | VTESSE LLC | 2022-05-26 | — | — | US | disclosed |
| US-4211839-A | SILVER HALIDE AND ORGANIC SILVER SALT PREPARED IN AN IMINO COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1980-07-08 | — | — | US | disclosed |
| US-4069759-A | ELECTROGRAPHY | CANON KABUSHIKI KAISHA (JA) | 1978-01-24 | — | — | US | disclosed |
| US-4036650-A | SILVER SALT, SILVER HALIDE, REDUCING AGENT | CANON KABUSHIKI KAISHA (JA) | 1977-07-19 | — | — | US | disclosed |
| US-RE29168-E | HEAT SENSITIVE, ANTIHALATION LAYER | EASTMAN KODAK COMPANY (US) | 1977-04-05 | — | — | US | disclosed |
| US-3984249-A | TREATING WITH HYDROGEN | EASTMAN KODAK COMPANY (US) | 1976-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220162155-A1 | L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF | OAT, OTC, ODC1 | ELANE 681/4885MAPT 425/4885ALDH1A1 286/4885 |
| US-20130211135-A1 | METHODS OF MAKING L-ORNITHINE PHENYL ACETATE | OTC, OAT, ODC1 | ELANE 1959/4885MAPT 737/4885ALDH1A1 476/4885 |
| US-20100280119-A1 | L-ORNITHINE PHENYL ACETATE AND METHODS OF MAKING THEREOF | OAT, OTC, PYGL | ELANE 626/4885MAPT 253/4885ALDH1A1 344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.